The China factor in big pharma pipelines

Thursday, April 30, 2026 | 12:00 PM - 1:00 PM ET

China has become impossible to ignore. BD teams at the world's top pharma spenders are picking up candidates in bulk — and that's creating a new kind of pressure on the top R&D 15 budgets that Endpoints' John Carroll has been tracking for over a decade.

We're bringing the news off the page this year, joined by some of the most senior R&D minds in the business. What does it mean for the pipelines, the competition, and where the next wave of R&D is actually coming from? Join the discussion to find out.

SPONSORED BY

Sponsorship opportunities are available.
Contact Meg at mestacio@endpointsnews.com to learn how you can support Endpoints' R&D 15 2026.

Questions about registration? Contact our support team.